{
    "organizations": [],
    "uuid": "3468ad519ffa2debe4c9ed66de3864ffd3c7f3ed",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-actinium-announces-154-mln-in-expe/brief-actinium-announces-15-4-mln-in-expected-gross-proceeds-from-recently-expired-rights-offering-idUSASB0C8QI",
    "ord_in_thread": 0,
    "title": "BRIEF-Actinium Announces $15.4 Mln In Expected Gross Proceeds From Recently Expired Rights Offering",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5 (Reuters) - Actinium Pharmaceuticals Inc:\n* ACTINIUM ANNOUNCES $15.4 MILLION IN EXPECTED GROSS PROCEEDS FROM RECENTLY EXPIRED RIGHTS OFFERING\n* ACTINIUM PHARMACEUTICALS INC - ‍EXPECTS CLOSING OF RIGHTS OFFERING WILL OCCUR ON OR ABOUT MARCH 6, 2018​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-05T20:37:00.000+02:00",
    "crawled": "2018-03-06T22:17:51.026+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "actinium",
        "pharmaceutical",
        "inc",
        "actinium",
        "announces",
        "million",
        "expected",
        "gross",
        "proceeds",
        "recently",
        "expired",
        "right",
        "offering",
        "actinium",
        "pharmaceutical",
        "inc",
        "closing",
        "right",
        "offering",
        "occur",
        "march",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}